James Scopa - Sep 14, 2021 Form 4 Insider Report for DICE Therapeutics, Inc. (DICE)

Role: Director
Signature: /s/ Scott Robertson as attorney-in-fact for James P. Scopa
Stock symbol: DICE
Transactions as of: Sep 14, 2021
Transactions value $: $102,000
Form type: 4
Date filed: 9/16/2021, 09:30 PM
Previous filing: May 14, 2021
Next filing: Nov 17, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DICE	Common Stock	Purchase	$102K	+6K	+12.04%	$17.00	55.8K	Sep 15, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DICE	Stock Option (right to buy)	Award	$0	+12.1K		$0.00	12.1K	Sep 14, 2021	Common Stock	12.1K	$17.00	Direct	F3
transaction	DICE	Stock Option (right to buy)	Award	$0	+8.26K		$0.00	8.26K	Sep 14, 2021	Common Stock	8.26K	$17.00	Direct	F4
transaction	DICE	Stock Option (right to buy)	Award	$0	+8.2K		$0.00	8.2K	Sep 14, 2021	Common Stock	8.2K	$17.00	Direct	F5
transaction	DICE	Stock Option (right to buy)	Award	$0	+5.6K		$0.00	5.6K	Sep 14, 2021	Common Stock	5.6K	$17.00	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of shares of Common Stock reported in the Reporting Holder's Form 3 reflected the conversion of derivative securities based on the midpoint of the Issuer's initial public offering range of $16.00 per share. The number of shares of Common Stock reflected in this Form 4 reflects the adjusted number of shares issued based on the higher initial public offering price of $17.00 per share, and does not reflect a disposition of shares.
F2	Certain of the shares are subject to the Issuer's right of repurchase if underlying vesting conditions are not met.
F3	The option vests as to 1/36th of the total shares monthly, beginning November 8, 2020, subject to the Reporting Holder's continued service to the Registrant.
F4	The option vests as to 1/36th of the total shares monthly, beginning January 1, 2021, subject to the Reporting Holder's continued service to the Registrant.
F5	The option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continued service to the Registrant.